Page last updated: 2024-11-05

bromcresol green

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bromcresol Green: An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6451
CHEMBL ID145704
CHEBI ID183839
SCHEMBL ID38763
MeSH IDM0002931

Synonyms (82)

Synonym
3',5',5''-tetrabrom-m-cresolsulfonephthalein
m-cresol,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-, s,s-dioxide
3',5',5''-tetrabromo-m-cresolsulfonephthalein
phenol,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-, s,s-dioxide
nsc-7817
tetrabromo-m-cresolphthalein sulfone
m-cresol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-, s,s-dioxide
phenol, 4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl-
nsc 7817
o-toluenesulfonic acid, alpha-hydroxy-, gamma-sultone
einecs 200-972-8
brn 0372527
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl-, s,s-dioxide
3',3'',5',5''-tetrabromo-m-cresolsulfonephthalein
4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl)phen- ol s,s-dioxide
bromocresol green sultone form, for microscopy (bot., hist., vit.), indicator (ph 3.8-5.4)
3,3-bis(3,5-dibromo-4-hydroxy-2-methylphenyl)benzo[c]1,2-oxathiolene-1,1-dione
nsc7817
baciilus calmette guerin vaccine
bromocresol green
76-60-8
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methyl-phenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-3-methyl-phenol
bromcresol green
bacillus calmette-guerin
bromocresol green sultone form, powder
bromocresol green, acs reagent, dye content 95 %
B-7890
bromocresol blue
B0579
B2401
B0578
B0114
CHEMBL145704 ,
bromocresol green, acs
bromocresolgreen
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methylphenol
CHEBI:183839
A838763
4-[3-[3,5-bis(bromanyl)-2-methyl-4-oxidanyl-phenyl]-1,1-bis(oxidanylidene)-2,1$l^{6}-benzoxathiol-3-yl]-2,6-bis(bromanyl)-3-methyl-phenol
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-3-methylphenol
cas-76-60-8
dtxsid9044459 ,
NCGC00255852-01
tox21_302105
dtxcid7024459
STL280536
4,4'-(1,1-dioxido-3h-2,1-benzoxathiole-3,3-diyl)bis(2,6-dibromo-3-methylphenol)
bdbm50420251
5-19-03-00460 (beilstein handbook reference)
8ygn0y942m ,
unii-8ygn0y942m
bcg [dye]
FT-0613998
AKOS015902660
gtpl4530
3,3-bis(3,5-dibromo-4-hydroxy-2-methylphenyl)-3h-2,1$l^{6}-benzoxathiole-1,1-dione
bromocresol green [inci]
bromcresol green [mi]
o-toluenesulfonic acid, .alpha.,.alpha.-bis(3,5-dibromo-4-hydroxy-o-tolyl)-.alpha.-hydroxy-, .gamma.-sultone
SCHEMBL38763
m-cresol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-, s,s-dioxide
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-, s,s-dioxide
tetrabromo-m-cresolsulfonphthalein
3',3'',5',5''-tetrabromo-m-cresol-sulfonephthalein
3',3'',5',5''-tetrabrom-m-cresolsulfonephthalein
bromo cresol green
3,3-bis(3,5-dibromo-4-hydroxy-2-methylphenyl)-3h-benzo[c][1,2]oxathiole 1,1-dioxide
J-610073
mfcd00005874
bromocresol green, jis special grade
D78150
bromocresol green, acs reagent
CS-W020884
Q418613
bromocresol green sultone form
AMY22376
bromocresol green solution
bromocresol verde
verde de bromocresol
vert de bromocresol
HY-W040144
bromocresol green, acs grade

Research Excerpts

Effects

The bromcresol green (BCG) assay has been used in microvascular studies to determine albumin in rat plasma. The method has been improved considerably by shortening the reaction time.

ExcerptReferenceRelevance
"The bromcresol green method has been improved considerably by shortening the reaction time before the absorbance is measured, as is described here."( Improved continuous-flow (SMAC) determination of serum albumin.
Akerlund, G; Cederblad, G; Hickey, BE; Hollender, A, 1978
)
0.74
"Bromcresol green (BCG) assay has been used in microvascular studies to determine albumin in rat plasma. "( Bromcresol green assay is nonspecific for rat plasma albumin.
Barber, BJ; Stanhope, VL, 1992
)
3.17

Dosage Studied

ExcerptRelevanceReference
"A spectrophotometric method is described for the determination of tilidine in its dosage forms (injection, drops, suppositories)."( Spectrophotometric determination of tilidine using bromocresol green and bromophenol blue.
Dobrila, ZS; Ljiljana, S; Ljiljana, Z, 1990
)
0.28
"A simple and sensitive method for the determination of clonidine in dosage forms is presented."( Spectrophotometric determination of clonidine in dosage forms using bromocresol green.
Agbaba, G; Panić, L; Zivanov-Stakić, D, 1990
)
0.28
" A selective late dye concentration dependent on the time is described for 3 triphenylmethane dyes namely bromphenol blue, bromcresol green and iodophenol blue after intravenous application in high dosage in malignant inoculated tumors and experimental tumor metastases in the mouse."( [Selective, time dependent accumulation of the triphenylmethane dyes bromphenol blue, bromoresol green and iodophenol blue in mouse tumors].
Graffi, A, 1981
)
0.47
"Three sensitive and accurate methods are presented for the determination of benazepril in its dosage forms."( Spectrophotometric methods for the determination of benazepril hydrochloride in its single and multi-component dosage forms.
Abdine, HH; El-Yazbi, FA; Shaalan, RA, 1999
)
0.3
" Conformity to Beer's law enabled the assay of dosage forms of the drug."( Simple spectrophotometric determination of cinnarizine in its dosage forms.
Abdine, H; Belal, F; Zoman, N, 2002
)
0.31
" This method can be applied to injectable pharmaceutical preparation dosage studied."( Spectrophotometric determination of etidocaine in pharmaceutical (dental) formulation.
Schapoval, EE; Silva, N, 2002
)
0.31
" The proposed methods have been applied successfully for the analysis of the drug in pure form and in its dosage forms."( Extractive spectrophotometric methods for the determination of oxomemazine hydrochloride in bulk and pharmaceutical formulations using bromocresol green, bromocresol purple and bromophenol blue.
El-Didamony, AM, 2005
)
0.33
"A simple and rapid extraction spectrophotometric procedure has been developed for the determination of tricyclic anti-depressant drugs such as trazodone (TZH), amineptine (APH) and amitriptyline (ATPH) hydrochlorides in pure form and in different dosage forms."( Spectrophotometric determination of trazodone, amineptine and amitriptyline hydrochlorides through ion-pair formation using methyl orange and bromocresol green reagents.
Mohamed, GG; Mohamed, NA; Nour El-Dien, FA, 2006
)
0.33
" Two sensitive, selective, and rapid spectrophotometric methods are described for the determination of tramadol in its dosage forms and in spiked human urine."( Use of two sulfonthalein dyes in the extraction-free spectrophotometric assay of tramadol in dosage forms and in spiked human urine based on ion-pair reaction.
Basavaiah, K; Rajendraprasad, N; Ramesh, PJ; Revannasiddappa, HD; Vinay, KB; Xavier, CM, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzofurans
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (27)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency8.67010.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency77.27200.002541.796015,848.9004AID1347395
RAR-related orphan receptor gammaMus musculus (house mouse)Potency5.41290.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency8.23850.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency12.15260.000221.22318,912.5098AID1259243; AID1259247; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency16.71490.013326.981070.7614AID1346978
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency9.85490.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency23.61040.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency11.21190.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.36080.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency11.54030.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency11.83320.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.23120.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency6.71260.001024.504861.6448AID743212
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency20.96040.023723.228263.5986AID743222; AID743241
caspase-3Homo sapiens (human)Potency16.71490.013326.981070.7614AID1346978
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency16.71490.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency8.52040.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259393; AID1259395
Histone H2A.xCricetulus griseus (Chinese hamster)Potency11.43770.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency21.88220.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency4.36610.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency26.10750.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency14.89720.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency14.89720.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency1.39590.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency1.18330.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier organic anion transporter family member 2A1Rattus norvegicus (Norway rat)Ki3.60000.03821.41225.8000AID679000
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID80631Percent relaxation of isolated guinea pig trachea.1998Bioorganic & medicinal chemistry letters, Mar-03, Volume: 8, Issue:5
New bronchodilators selected by molecular topology.
AID679398TP_TRANSPORTER: inhibition of PAH uptake (PAH: 50 uM, BCG: 1000 uM) in Xenopus laevis oocytes1999Molecular pharmacology, Sep, Volume: 56, Issue:3
The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1.
AID80624Percent relaxation using isolated guinea pig trachea.1998Bioorganic & medicinal chemistry letters, Mar-03, Volume: 8, Issue:5
New bronchodilators selected by molecular topology.
AID679000TP_TRANSPORTER: inhibition of PGF2alpha uptake in PGT-expressing HeLa cells1995Science (New York, N.Y.), May-12, Volume: 268, Issue:5212
Identification and characterization of a prostaglandin transporter.
AID1345164Rat OATP2A1 (SLCO family of organic anion transporting polypeptides)1995Science (New York, N.Y.), May-12, Volume: 268, Issue:5212
Identification and characterization of a prostaglandin transporter.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (247)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990124 (50.20)18.7374
1990's28 (11.34)18.2507
2000's40 (16.19)29.6817
2010's41 (16.60)24.3611
2020's14 (5.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.15 (24.57)
Research Supply Index5.55 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index95.93 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.39%)5.53%
Reviews5 (1.95%)6.00%
Case Studies1 (0.39%)4.05%
Observational1 (0.39%)0.25%
Other248 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]